Hasil Pencarian (1)
small molecule | CAS: 1056634-68-4
Momelotinib is a Janus Kinase 1 (JAK1) and 2 (JAK2) inhibitor. It is a competitive inhibitor of JAK ATP binding.[A261566] First approved by the FDA on September 15, 2023,[L48206] momelotinib is used to treat myelofibrosis.[L48186] Myelofibrosis (MF) is a grou…
Kategori:
Acids, CarbocyclicAmidesAntineoplastic Agents
+24
Target Protein:
Tyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2Tyrosine-protein kinase JAK3
+3
Waktu ParuhThe elimination hal…
Vol. DistribusiThe mean (%CV) appa…
KlirensThe mean (%CV) clea…
Genetik
-